BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Durr ML, Mydlarz WK, Shao C, Zahurak ML, Chuang AY, Hoque MO, Westra WH, Liegeois NJ, Califano JA, Sidransky D, Ha PK. Quantitative methylation profiles for multiple tumor suppressor gene promoters in salivary gland tumors. PLoS One 2010;5:e10828. [PMID: 20520817 DOI: 10.1371/journal.pone.0010828] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Todd R. The Molecular Biology of Benign and Malignant Salivary Gland Tumors. Salivary Gland Pathology 2021. [DOI: 10.1002/9781119730248.ch9] [Reference Citation Analysis]
2 Dos Santos ES, Ramos JC, Normando AGC, Mariano FV, Paes Leme AF. Epigenetic alterations in salivary gland tumors. Oral Dis 2020;26:1610-8. [PMID: 31829479 DOI: 10.1111/odi.13253] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 Sumi M, Nakamura T. Salivary gland carcinoma: Prediction of cancer death risk based on apparent diffusion coefficient histogram profiles. PLoS One 2018;13:e0200291. [PMID: 29975742 DOI: 10.1371/journal.pone.0200291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Wen G, Wang H, Zhong Z. Associations of RASSF1A, RARβ, and CDH1 promoter hypermethylation with oral cancer risk: A PRISMA-compliant meta-analysis. Medicine (Baltimore) 2018;97:e9971. [PMID: 29538221 DOI: 10.1097/MD.0000000000009971] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
5 Ling S, Rettig EM, Tan M, Chang X, Wang Z, Brait M, Bishop JA, Fertig EJ, Considine M, Wick MJ, Ha PK. Identification of methylated genes in salivary gland adenoid cystic carcinoma xenografts using global demethylation and methylation microarray screening. Int J Oncol 2016;49:225-34. [PMID: 27212063 DOI: 10.3892/ijo.2016.3532] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
6 Yin LX, Ha PK. Genetic alterations in salivary gland cancers. Cancer 2016;122:1822-31. [PMID: 26928905 DOI: 10.1002/cncr.29890] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
7 Wang Z, Ling S, Rettig E, Sobel R, Tan M, Fertig EJ, Considine M, El-Naggar AK, Brait M, Fakhry C, Ha PK. Epigenetic screening of salivary gland mucoepidermoid carcinoma identifies hypomethylation of CLIC3 as a common alteration. Oral Oncol 2015;51:1120-5. [PMID: 26490796 DOI: 10.1016/j.oraloncology.2015.09.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
8 Todd R. The Molecular Biology of Benign and Malignant Salivary Gland Tumors. Salivary Gland Pathology 2015. [DOI: 10.1002/9781118949139.ch8] [Reference Citation Analysis]
9 Kondo Y, Kikuchi T, Esteban JC, Kumaki N, Ogura G, Inomoto C, Hirabayashi K, Kajiwara H, Sakai A, Sugimoto R, Otsuru M, Okami K, Tsukinoki K, Nakamura N. Intratumoral heterogeneity of HER2 protein and amplification of HER2 gene in salivary duct carcinoma. Pathol Int 2014;64:453-9. [PMID: 25209856 DOI: 10.1111/pin.12195] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
10 Tan M, Shao C, Bishop JA, Feng Z, Trock BJ, Westra WH, Ha PK. Aquaporin-1 promoter hypermethylation is associated with improved prognosis in salivary gland adenoid cystic carcinoma. Otolaryngol Head Neck Surg 2014;150:801-7. [PMID: 24493792 DOI: 10.1177/0194599814521569] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
11 Scesnaite A, Jarmalaite S, Mueller M, Agaimy A, Zenk J, Hartmann A, Iro H, Peters B, Schwarz S, Schneider-Stock R. Prognostic value of O-6-methylguanine-DNA methyltransferase loss in salivary gland carcinomas. Head Neck 2014;36:1258-67. [PMID: 25201059 DOI: 10.1002/hed.23445] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Bell D, Hanna EY. Head and neck adenoid cystic carcinoma: what is new in biological markers and treatment? Current Opinion in Otolaryngology & Head and Neck Surgery 2013;21:124-9. [DOI: 10.1097/moo.0b013e32835c05fd] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
13 Shao C, Tan M, Bishop JA, Liu J, Bai W, Gaykalova DA, Ogawa T, Vikani AR, Agrawal Y, Li RJ, Kim MS, Westra WH, Sidransky D, Califano JA, Ha PK. Suprabasin is hypomethylated and associated with metastasis in salivary adenoid cystic carcinoma. PLoS One 2012;7:e48582. [PMID: 23144906 DOI: 10.1371/journal.pone.0048582] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
14 Poeta ML, Massi E, Parrella P, Pellegrini P, De Robertis M, Copetti M, Rabitti C, Perrone G, Muda AO, Molinari F. Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumors. Genes Chromosomes Cancer. 2012;51:1133-1143. [PMID: 22927297 DOI: 10.1002/gcc.21998] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
15 Ettl T, Schwarz-furlan S, Gosau M, Reichert TE. Salivary gland carcinomas. Oral Maxillofac Surg 2012;16:267-83. [DOI: 10.1007/s10006-012-0350-9] [Cited by in Crossref: 63] [Cited by in F6Publishing: 71] [Article Influence: 6.3] [Reference Citation Analysis]
16 Bell D, Hanna EY. Salivary gland cancers: biology and molecular targets for therapy. Curr Oncol Rep 2012;14:166-74. [PMID: 22246609 DOI: 10.1007/s11912-012-0220-5] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
17 Liu J, Shao C, Tan ML, Mu D, Ferris RL, Ha PK. Molecular biology of adenoid cystic carcinoma. Head Neck 2012;34:1665-77. [PMID: 22006498 DOI: 10.1002/hed.21849] [Cited by in Crossref: 49] [Cited by in F6Publishing: 58] [Article Influence: 4.5] [Reference Citation Analysis]
18 Demokan S, Dalay N. Role of DNA methylation in head and neck cancer. Clin Epigenetics. 2011;2:123-150. [PMID: 22704334 DOI: 10.1007/s13148-011-0045-3] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
19 Shao C, Sun W, Tan M, Glazer CA, Bhan S, Zhong X, Fakhry C, Sharma R, Westra WH, Hoque MO, Moskaluk CA, Sidransky D, Califano JA, Ha PK. Integrated, genome-wide screening for hypomethylated oncogenes in salivary gland adenoid cystic carcinoma. Clin Cancer Res 2011;17:4320-30. [PMID: 21551254 DOI: 10.1158/1078-0432.CCR-10-2992] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 4.8] [Reference Citation Analysis]
20 Shao C, Bai W, Junn JC, Uemura M, Hennessey PT, Zaboli D, Sidransky D, Califano JA, Ha PK. Evaluation of MYB promoter methylation in salivary adenoid cystic carcinoma. Oral Oncol 2011;47:251-5. [PMID: 21324728 DOI: 10.1016/j.oraloncology.2011.01.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
21 Liu W, Zhu E, Wang R, Wang L, Liu T. CXCL12 G801A polymorphism is associated with an increased risk of benign salivary gland tumors in the Chinese population. Med Oncol 2012;29:677-81. [PMID: 21298365 DOI: 10.1007/s12032-011-9838-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
22 Bell A, Bell D, Weber RS, El-Naggar AK. CpG island methylation profiling in human salivary gland adenoid cystic carcinoma. Cancer 2011;117:2898-909. [PMID: 21692051 DOI: 10.1002/cncr.25818] [Cited by in Crossref: 81] [Cited by in F6Publishing: 86] [Article Influence: 7.4] [Reference Citation Analysis]